CELLIVIA 3 S.A
+ business areaBioPharma R&D+Services
+ annual revenue
2020 – 602,283 PLN
2021 – 700,522 PLN
+ workforce (estimated if not reported)
2021 – 5
+ depreciation & amortization
2020 – 19,532 PLN
2021 – 79,312 PLN
Cellivia 3 S.A. is a company combining knowledge in the field of: biotechnology, medicine and robotics. The company deals with: material banking
from the area of the oral cavity, development of technology for the production of advanced therapy drugs, research in the field of cell and tissue bioengineering, biotechnology and biomedicine, as well as the application of bioengineering and robotics in the medical industry.